Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia

Cancer

Volumn 110, Issue 10, 2007, Pages 2321-2330

  Hinds, Pamela S ^a   Hockenberry, Marilyn J ^b   Gattuso, Jami S ^a   Srivastava, Deo Kumar ^a   Tong, Xin ^a   Jones, Heather ^c   West, Nancy ^a   McCarthy, Kathy S ^b   Sadeh, Avi ^d   Ash, Monica ^e   Fernandez, Cheryl ^f   Pui, Ching Hon ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d TEL AVIV UNIVERSITY   (Israel)

^e OUR LADY OF THE LAKE REGIONAL MEDICAL CENTER   (United States)

^f Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Actigraphy; Acute lymphoblastic leukemia; Dexamethasone; Fatigue; Pediatric sleep; Sleep diary

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; VINCRISTINE;

ACTIMETRY; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AMBULATORY MONITORING; ARTICLE; CHILD; CHILD BEHAVIOR; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEVICE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITOR; PARENT; PATIENT MONITORING; PRIORITY JOURNAL; RATING SCALE; SELF REPORT; SLEEP; SLEEP TIME; SLEEP WAKING CYCLE; WRIST;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; FATIGUE; FEMALE; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SLEEP;

EID: 36049017361     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23039     Document Type: Article

References (54)

1. Agthe AG, Doffel W, Neuendank A, et al. Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemia. In: Pieters R, Kaspers GJL, Veerman AJP, editors. Drug Resistance in Leukemia and Lymphoma II. Amsterdam, the Netherlands: Harwood Academic Publishers; 1997:51-58.
2. Veerman AJP, Hahlen K, Kamps WA. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of Protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol. 1996;14:911-918.
3. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987;5:202-207.
4. Tanghe A, Delforge A, Bernier M, et al. Apoptosis of B-chronic lymphocytic leukemia (CLL) cells in presence of glucocorticoids and modulation of their effect by interleukin-4. In: Pieters R, Kaspers GJL, Veerman AJP, editors. Drug Resistance in Leukemia and Lymphoma II. Amsterdam, the Netherlands: Harwood Academic Publishers; 1997:141-145.
5. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97:1211-1218.
6. Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphocytic leukemia: 1983-1995. Leukemia. 2000;14:2223-2233.
7. Jones B, Freeman AI, Shuster JJ, et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol. 1991;19:269-275.
8. Mitchell CD, Richards SM, Kinsey SE, et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL 97 randomized trial. Br J Haematol. 2005;129:734-745.
9. Pui C-H, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166-178.
10. Bleyer WA, Poplack DG, Balis FM. Pharmacokinetics of commonly used leukemic agents in children. In: Kobayashi N, Akera T, Mizutani S, editors. Childhood Leukemia: Present Problems and Future Prospects. New York, NY: Springer-Verlag; 1991:149-155.
11. Kaspers GJ, Pieters R, Veerman AP. Glucocorticoid sensitivity and resistance in childhood leukemia. In: Pieters R, Kaspers GJL, Veerman AJP, editors. Drug Resistance in Leukemia and Lymphoma II. Amsterdam, the Netherlands: Harwood Academic Publishers; 1997:95-103.
12. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003;101:3809-3817.
13. Drigan R, Spirito A, Gelber RD. Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia. Med Pediatr Oncol. 1992;20:13-21.
14. Harris JC, Carel CA, Rosenberg LA, Joshi P, Leventhal BG. Intermittent high dose corticosteroid treatment in childhood cancer. J Am Acad Child Psychiatry. 1986;25:120-124.
15. Watanabe TK, Sylvester CE, Manaligod JM. Mania or panic associated with dexamethasone chemotherapy in adolescents. J Adolesc Health. 1994;15:345-347.
16. Zoorob RJ, Cender D. A different look at corticosteroids. Am Fam Physician. 1998;58:443-450.
17. Jenni OG, O'Connor BB. Children's sleep: an interplay between culture and biology. Pediatrics. 2005;115:204-216.
18. Mindell JA, Owens JA, Carksadon MA. Developmental features of sleep. Child Adolesc Psychiatr Clin N Am. 1999;8:695-725.
19. Glaze DG. Childhood insomnia: why Chris can't sleep. Pediatr Clin North Am. 2004;51:33-50.
20. Grigg-Damberger M. Neurologic disorders masquerading as pediatric sleep problems. Pediatr Clin North Am. 2004;51:89-115.
21. Hoban TF. Sleep and its disorders in children. Semin Neurol. 2004;24:327-340.
22. Hoban TF, Chervin RD. Assessment of sleepiness in children. Semin Pediatr Neurol. 2004;8:216-228.
23. Fallone G, Owens JA, Deane J. Sleepiness in children and adolescents: clinical implications. Sleep Med Rev. 2002;6:287-306.
24. Fallone G, Acebo C, Arnedt J, Seifer R, Carskadon M. Effects of acute sleep restriction on behavior, sustained attention, and response inhibition in children. Percept Mot Skills. 2001;93:213-229.
25. Hansen DE, Vanderberg B. Neurophysiological features and differential diagnosis of sleep apnea syndrome in children. J Clin Child Psychol. 1997;26:304-310.
26. Lewin DS, England SJ, Rosen RC. Neuropsychological sequelae of obstructive sleep apnea in children. Sleep Res. 1996;25:278. Abstract.
27. Yang CK, Kim JK, Patel SR, et al. Age-related changes in sleep/wake patterns among Korean teenagers. Pediatrics. 2005;115:250-256.
28. Hansen M, Janssen I, Schiff A, et al. The impact of school daily schedule on adolescent sleep. Pediatrics. 2005;115:1555-1561.
29. Owens J, Oppipari L, Nobile C, Spirito A. Sleep and day-time behaviors in children with obstructive sleep apnea and behavioral sleep disorder. Pediatrics. 1998;102:1178-1184.
30. Randazzo AC, Muehlbach MJ, Schweitzer PK, et al. Cognitive function following acute sleep restriction in children ages 10-14. Sleep. 1998;21:861-868.
31. Sadeh A, Gruber R, Raviv A. Sleep, neurobehavioral functioning, and behavior problems in school-age children. Child Dev. 2002;73:405-417.
32. Sadeh A, Gruber R, Raviv A. The effects of sleep restriction and extension on school-age children: what a difference an hour makes. Child Dev. 2003;74:444-455.
33. Hart CN, Palermo TM, Rosen CL. Health-related quality of life among children presenting to a pediatric sleep disorders clinic. Behav Sleep Med. 2005;3:4-17.
34. Pilcher JJ, Ott ES. The relationship between sleep and measures of health and well-being in college students: a repeated measures approach. Behav Med. 1998;23:170-178.
35. Mindell JA, Owens JA. A Clinical Guide to Pediatric Sleep: Diagnosis and Management of Sleep Problems. Philadelphia, Pa: Lippincott, Williams & Wilkins Publishers; 2003.
36. Sadeh A. Stress, trauma and sleep in children. Child Adolesc Psychiatr Clin N Am. 1996;5:685-700.
37. Puig-Antich J, Goetz R, Hanlon C, et al. Sleep architecture and REM sleep measures in prepubertal children with major depression. A controlled study. Arch Gen Psychiatry. 1982;39:932-939.
38. Puig-Antich J, Goetz R, Hanlon C, Tabrizi MA, Davies M, Weitzman ED. Sleep architecture and REM sleep measures in prepubertal major depressives. Studies during recovery from the depressive episode in a drug-free state. Arch Gen Psychiatry. 1983;40:187-192.
39. Acebo C, Sadeh A, Seifer R, et al. Estimating sleep patterns with activity monitoring in children and adolescents: how many nights are necessary for reliable measures? Sleep. 1999;22:95-103.
40. Sadeh A, Sharkey KM, Carskadon MA. Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep. 1994;17:201-207.
41. Sadeh A, Acebo C, Seifer R, et al. Activity-based assessment of sleep-wake patterns during the 1st year of life. Infant Behav Dev. 1995;18:329-337.
42. Hinds PS, Hockenberry-Eaton MA. Developing a research program on fatigue in children and adolescents with cancer. J Pediatr Oncol Nurs. 2001;18(2 suppl 1):3-12.
43. Hockenberry-Eaton M, Hinds P. Fatigue in children and adolescents with cancer: evolution of a program study. Semin Oncol Nurs. 2000;16:261-272.
44. Hockenberry MJ, Hinds PS, Barrera P, et al. Three instruments to assess fatigue in children with cancer: the child, parent and staff perspectives. J Pain Symptom Manage. 2003;25:319-328.
45. Hinds PS, Hockenberry M J, Tong X, et al. Validity and reliability of a new instrument to measure cancer-related fatigue in adolescents. J Pain Symptom Manage. 2007;July 13; [Epub ahead of print].
46. Sadeh A, Hauri PJ, Kripke DF, Lavie P. The role of actigraphy in the evaluation of sleep disorders. Sleep. 1995;18:288-302.
47. Sadeh A, McGuire JPD, Sachs H, et al. Sleep and psychological characteristics of children on a psychiatric inpatient unit. J Am Acad Child Adolesc Psychiatry. 1995;34:813-819.
48. Vena C, Parker K, Cunningham M, et al. Sleep-wake disturbances in people with cancer. Part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol Nurs Forum. 2004;31:735-746.
49. Sadeh A, Horowitz I, Wolach-Benodis L, Wolach B. Sleep and pulmonary function in children with well-controlled, stable asthma. Sleep. 1998;21:379-384.
50. Gedaly-Duff V, Lee KA, Nail LM, et al. Pain, sleep disturbance, and fatigue in children with leukemia and their parents: a pilot study. Oncol Nurs Forum. 2006;33:641-646.
51. Hinds PS, Hockenberry M, Rai SN, et al. Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol Nurs Forum. 2007;34:393-402.
52. Riter S, Wills L. Sleep wars: research and opinion. Pediatr Clin North Am. 2004;51:1-13.
53. Carskadon MA, Wolfson AR, Acebo C, Tzischinsky O, Seifer R. Adolescent sleep patterns, circadian timing, and sleepiness at a transition to early school days. Sleep. 1998;21:871-881.
54. Sadeh A, Raviv A, Gruber R. Sleep patterns and sleep disruptions in school-age children. Dev Psychol. 2000;36:291-301.